RNF14

RNF14 (ARA54) is a RING-domain E3 ubiquitin ligase that couples substrate ubiquitination to transcriptional and translational quality-control processes (PMID:11322894, PMID:37951216). Its catalytic activity depends on an intact RING domain, through which it engages class III ubiquitin-conjugating enzymes (UBE2E2, UbcH6/UBE2E1, UBE2E3) to drive E2-dependent ubiquitination, with the RING point mutant C220S abolishing this activity (PMID:11322894). In its best-defined role, RNF14 resolves aldehyde-induced covalent RNA-protein crosslinks during translation: ribosome collisions at mRNA-crosslinked protein adducts trigger RNF14-dependent decoration of the adducts with atypical K6- and K48-linked ubiquitin chains, targeting them for proteasomal degradation (PMID:37951216). RNF14 also acts as a substrate-selective ligase in the nucleus, directly binding neuropathy target esterase (NTE) and promoting its proteasomal degradation in a RING-dependent manner (PMID:26606397). Independently of its ligase output, RNF14 functions as a ligand-dependent androgen receptor (AR) coactivator that enhances AR-mediated transactivation, an activity requiring RNF14 homodimerization; transgelin and hnRNP A1 negatively regulate this function by disrupting RNF14 homodimerization and AR–RNF14 complexes (PMID:10085091, PMID:11673464, PMID:17082327, PMID:17110431). RNF14 additionally promotes cyclin D1 transcription in an AR-independent manner, and its depletion causes G1 arrest (PMID:17510080).

1. 1999 Medium

   Established RNF14's first functional context by showing it is a ligand-dependent AR coactivator, framing it as a modulator of nuclear receptor transcription rather than an orphan RING protein.

   Evidence Yeast two-hybrid screen plus reporter assays and dominant-negative truncation in DU145 prostate cancer cells

   PMID:10085091

   Open questions at the time

   • Did not define a catalytic or enzymatic activity
   • Mechanism of AR enhancement at the molecular level unresolved
2. 2001 High

   Defined RNF14 as a bona fide E3 ubiquitin ligase by mapping its RING-domain dependence and class III E2 partnership, converting it from a transcriptional cofactor into an enzyme.

   Evidence Yeast two-hybrid with deletion/point mutants, in vitro autoubiquitination with insect-cell protein, and in vivo ubiquitination with MG132 in COS-7 cells

   PMID:11322894

   Open questions at the time

   • No physiological substrate identified at this stage
   • Functional link between ligase activity and AR coactivation not established
3. 2001 Medium

   Showed that RNF14 homodimerization is mechanistically required for AR coactivation, identifying oligomerization as a regulatable node controlling its transcriptional function.

   Evidence Mutagenesis (E472K), mammalian two-hybrid, and doxycycline-inducible stable transfection assays in LNCaP cells

   PMID:11673464

   Open questions at the time

   • Structural basis of dimerization not resolved
   • Relationship between dimerization and ligase activity unclear
4. 2001 Low

   Localized RNF14 to both cytoplasm and nucleus, consistent with dual roles in transcription and post-transcriptional control.

   Evidence GFP-fusion fluorescence microscopy in COS-7 cells

   PMID:11322894

   Open questions at the time

   • Single localization experiment with GFP fusion, no functional consequence linked
   • No characterization of regulated trafficking between compartments
5. 2006 Medium

   Identified transgelin and hnRNP A1 as negative regulators that act by disrupting RNF14 homodimerization and AR–RNF14 complexes, explaining how RNF14 coactivation is restrained.

   Evidence Co-immunoprecipitation, subcellular localization, and siRNA rescue with reporter assays in LNCaP cells

   PMID:17082327 PMID:17110431

   Open questions at the time

   • Whether regulation depends on RNF14 ligase activity not tested
   • In vivo relevance to prostate cancer progression not established
6. 2007 Medium

   Revealed an AR-independent transcriptional role by showing RNF14 drives cyclin D1 transcription and is required to prevent G1 arrest, broadening its function beyond nuclear-receptor signaling.

   Evidence siRNA knockdown with qPCR, Western blot, mRNA/protein stability assays, and cell-cycle FACS in T98G cells

   PMID:17510080

   Open questions at the time

   • Direct mechanism by which RNF14 promotes cyclin D1 transcription unknown
   • Whether ubiquitin ligase activity is involved unresolved
7. 2015 Medium

   Provided the first defined physiological substrate by establishing RNF14 as the E3 ligase that ubiquitinates and destabilizes NTE, linking its catalytic activity to control of a specific nuclear target.

   Evidence Co-IP for direct interaction, overexpression/siRNA with Western blot, RING point mutagenesis, and proteasome inhibition

   PMID:26606397

   Open questions at the time

   • Ubiquitin chain linkage on NTE not characterized
   • Physiological context of NTE regulation not defined
8. 2023 High

   Defined RNF14's most mechanistically resolved role: translation-coupled resolution of RNA-protein crosslinks via ribosome-collision-triggered K6/K48 ubiquitination of crosslinked adducts for proteasomal degradation.

   Evidence PAR-CL crosslinking in human cells, ubiquitin chain-linkage mass spectrometry, RNF14 knockout, ribosome profiling, and proteasome inhibitor assays

   PMID:37951216

   Open questions at the time

   • E2 partner used in this pathway not specified
   • How RNF14 is recruited to collided ribosomes not defined
   • Relationship to its nuclear/transcriptional roles unknown

• It remains unknown how RNF14's distinct activities — AR coactivation, cyclin D1 transcription, NTE degradation, and translation-coupled crosslink resolution — are integrated or whether they share a common regulatory logic.
• No unifying model connecting transcriptional and quality-control functions
• Mechanism distinguishing ligase-dependent from ligase-independent roles unresolved
• Recruitment determinants for each substrate context undefined